top of page
  • LinkedIn
shutterstock_572848084.jpg

Transforming Chronic Wound Care

Aurase Wound Gel is a breakthrough wound therapeutic for patients with chronic wounds, which aims to return wounds to healing

SolasCure Webste Wireframe_D2-32.png

Every year ~100 million people suffer from chronic wounds worldwide

SolasCure Webste Wireframe_D2-31.png

Despite many innovations in wound care over the years, chronic wound healing rates have barely changed

SolasCure Webste Wireframe_D2-33.png

 Lack of easy-to-use, effective treatments to debride chronic wounds and return them to healing leaves patients suffering and is a huge burden on healthcare systems

Option 1_TMCi.jpg

Selected for the Innovate UK & TMC Innovation Accelerator Program, in partnership with Texas Medical Center, in 2024

Awarded the Biomedical Catalyst Grant by Innovate UK, the UK's innovation agency in 2024

Awarded EIC Accelerator Grant by the European Innovation Council in 2023

Selected as a 2023 Life Sciences Innovator by UK Department for Business and Trade

1st place in the Biotech Category at EIT Health Catapult (European Institute of Innovation & Technology) in 2022

Winner of the 2019 URGO Mentorship Program

Industry Recognition

pattern.jpg

Successful Phase IIa Clinical Trial Completed

Latest News

6 November 2024 at 08:00:00

PRESS RELEASES

6 November 2024

SolasCure and U.S. Army Institute of Surgical Research collaborate for combat wound care

21 August 2024 at 11:00:00

THOUGHT LEADERSHIP

21 August 2024

Wound Care Voices: Why the Battle Against Chronic Wounds is Worth Fighting

4 July 2024 at 11:00:00

THOUGHT LEADERSHIP

4 July 2024

Wound Bed Preparation: Addressing the Urgent Need for Effective Solutions

Get in touch with us

By submitting this message I consent to share my name and email address with SolasCure

Change is needed in current health systems – patients, practitioners, and regulators across the industry are in urgent need of high-impact innovations
in chronic wound care

SOLASCURE IS AT THE FOREFRONT OF ADDRESSING THIS DEMAND

Aurase Wound Gel, a hydrogel containing the proteolytic enzyme Tarumase, is an enzymatic debrider that aims to eliminate slough, disrupt bacterial biofilm leading to reduced bioburden, and promote wound bed preparation and healing. Tarumase is a highly-specific fibrinolytic enzyme cloned from maggot saliva, perfectly optimised by evolution for wound bed preparation.

bottom of page